Quantimetrix Urine Chemistry Control Set Dipper Urinalysis Dipstick Testing Levels 1 & 2 6 X 15 ...

FDA Device Recall #Z-0138-2025 — Class II — September 17, 2024

Recall Summary

Recall Number Z-0138-2025
Classification Class II — Moderate risk
Date Initiated September 17, 2024
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Mckesson Medical-Surgical Inc. Corporate Office
Location Richmond, VA
Product Type Devices
Quantity 1 BOX

Product Description

Quantimetrix Urine Chemistry Control Set Dipper Urinalysis Dipstick Testing Levels 1 & 2 6 X 15 mL-IVD intended as a control for urinalysis reagent strips, microalbumin, and creatinine by listed test methods.

Reason for Recall

The Quantimetrix Dipper Urinalysis Dipstick control was shipped without the validated summer packaging and may have been exposed to temperatures above 25¿C. This may lead to delay in patients' results.

Distribution Pattern

US Nationwide distribution in the state of DC.

Lot / Code Information

UDI-DI: 896863002134

Other Recalls from Mckesson Medical-Surgical Inc. Corpor...

Recall # Classification Product Date
Z-2337-2025 Class II Clearview Strep A Exact II Dipstick Respiratory... Jul 30, 2025
Z-1842-2025 Class II ABBOTT DIAGNOSTICS ARCH AUSAB ANTI-HBS (100/EA)... Apr 24, 2025
Z-1837-2025 Class II ORTHO CLINICAL DIAGNOSTICS INC VITROS BUN (60/C... Apr 24, 2025
Z-1854-2025 Class II SEKISUI DIAGNOSTICS LLC SERUM HCG OSOMGENZME CO... Apr 24, 2025
Z-1846-2025 Class II ABBOTT POINT OF CARE TEST CREA I-STAT (25/BX) A... Apr 24, 2025

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.